// App-Quantinova.ai

: Distribution of biomarkers in severe asthma and severe uncontrolled asthma

Researchers

Presenter

  • Bo Ding

Principal Investigators

  • Stephanie Chen

  • Aayushi Agrawal

  • Divyansh Srivastava

  • Jaime Solorzano

  • Bill Cook

  • Alberto Papi

  • Helen K Reddel

Medical Centers

  • BioPharmaceuticals Medical AstraZeneca Gaithersburg Maryland United States

  • GMA Diabetes, BioPharmaceuticals Med, AstraZeneca, Cambridge, United Kingdom

  • Department of Translational Medicine, University of Ferrara, Ferrara, Italy

  • ZS Associates, Pune, India

  • Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia.

  • Early RIA, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

  • ZS Associates, New Delhi, India

Locations

  • Sweden

  • United States

  • India

  • United Kingdom

  • Italy

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Autoimmune (AI)

Disease

  • Asthma

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • Nitric oxide

Outcome

  • N/A

Study Design

  • Observational

Phase

  • N/A

Study Id's

  • NCT02760329

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved